Covered recipient · General Payments record
NGOC THI BICH VU
Allopathic & Osteopathic Physicians Allergy & Immunology
General Payments · PY2018–2024
$3,299.01
- Reported across 145 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $277.29 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Kaleo, Inc. | $80.80 | 3 |
| Acerta Pharma LLC | $74.10 | 4 |
| GENZYME CORPORATION | $46.84 | 2 |
| Genentech USA, Inc. | $30.48 | 1 |
| OptiNose US, Inc. | $29.96 | 1 |
| GlaxoSmithKline, LLC. | $15.11 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $14.01 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104676631 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.91 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105602718 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.19 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105208113 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.99 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104703307 | CMS |
| Genentech USA, Inc. | $30.48 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133080568 | CMS |
| GENZYME CORPORATION | $21.33 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139986180 | CMS |
| GENZYME CORPORATION | $25.51 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139986240 | CMS |
| GlaxoSmithKline, LLC. | $15.11 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116141566 | CMS |
| kaleo, Inc. | $28.88 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126628624 | CMS |
| kaleo, Inc. | $21.78 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126628626 | CMS |
| kaleo, Inc. | $30.14 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126628628 | CMS |
| Optinose US, Inc. | $29.96 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142188870 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.